Reporter
Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.
Latest stories
A look back at 25 years of the Globe 100
By Robert Weisman , Globe Staff
Year by year, the Globe 100 has chronicled the shifting dominance of local industries and the emergence of promising new ventures.
Net income rises for Partners HealthCare System
By Robert Weisman , Globe Staff
Earnings rose despite a state decision to drop an assessment on the insurer’s newly acquired health insurance division.
Novartis, Amgen join venture fund
By Robert Weisman , Globe Staff
Biopharmaceutical companies Novartis AG and Amgen Inc. have signed on as limited partners in a new $265 million venture capital fund.
Algeta wins FDA approval for prostate cancer treatment
By Robert Weisman , Globe Staff
The drug, called Xofigo, treats castration-resistant prostate cancer, a disease that afflicts tens of thousands of men in the US.